FDA rejects Eli Lilly’s proposed Alzheimer’s treatment, says more data needed
January 19, 2023 at 19:16 PM EST
The setback could delay a potential commercial introduction of the highly anticipated drug by at least several months, if the Food and Drug Administration eventually decides to approve it.